Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

Mostrar otras versiones (2)
Detalles Bibliográficos
Autores principales: Maruyama, Hiroki, Miyata, Kaori, Mikame, Mariko, Taguchi, Atsumi, Guili, Chu, Shimura, Masaru, Murayama, Kei, Inoue, Takeshi, Yamamoto, Saori, Sugimura, Koichiro, Tamita, Koichi, Kawasaki, Toshihiro, Kajihara, Jun, Onishi, Akifumi, Sugiyama, Hitoshi, Sakai, Teiko, Murata, Ichijiro, Oda, Takamasa, Toyoda, Shigeru, Hanawa, Kenichiro, Fujimura, Takeo, Ura, Shigehisa, Matsumura, Mimiko, Takano, Hideki, Yamashita, Satoshi, Matsukura, Gaku, Tazawa, Ryushi, Shiga, Tsuyoshi, Ebato, Mio, Satoh, Hiroshi, Ishii, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609257/
https://www.ncbi.nlm.nih.gov/pubmed/30728527
http://dx.doi.org/10.1038/s41436-019-0447-8
Mostrar todas las versiones(3)

Ejemplares similares